Cargando…

High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group

Introduction. Osteosarcoma relapse has a poor prognosis, with less than 25% survival at 5 years. We describe the experience of the French Society of Paediatric Oncology (SFCE) with high dose (HD) thiotepa and autologous stem cell transplantation (ASCT) in 45 children with relapsed osteosarcoma. Pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marec-Berard, Perrine, Segura-Ferlay, Céline, Tabone, Marie-Dominique, Pacquement, Helene, Lervat, Cyril, Gentet, Jean-Claude, Schmitt, Claudine, Gaspar, Nathalie, Brugières, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941142/ https://www.ncbi.nlm.nih.gov/pubmed/24672280 http://dx.doi.org/10.1155/2014/475067

Ejemplares similares

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study
por: Tabone, Marie-Dominique, et al.
Publicado: (2017)

Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases
por: Guillon, Maud AM, et al.
Publicado: (2011)

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
por: Thebault, Eric, et al.
Publicado: (2021)

Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)
por: Penel-Page, Mathilde, et al.
Publicado: (2015)

Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE)
por: Rudant, Jérémie, et al.
Publicado: (2007)

Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France
por: Corvest, Victoria, et al.
Publicado: (2022)

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)(☆)
por: Gaspar, N., et al.
Publicado: (2021)

Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)
por: de Tersant, Marie, et al.
Publicado: (2020)

Road Traffic and Childhood Leukemia: The ESCALE Study (SFCE)
por: Amigou, Alicia, et al.
Publicado: (2011)

Bone Sarcomas: From Biology to Targeted Therapies
por: Gaspar, Nathalie, et al.
Publicado: (2012)

Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping
por: Entz-Werle, N, et al.
Publicado: (2003)

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial
por: Fox, Christopher P., et al.
Publicado: (2021)

Whither thiotepa (for patients in the USA)?
por: Dardis, Christopher, et al.
Publicado: (2015)

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
por: Ramaswamy, Kavitha, et al.
Publicado: (2022)

Thiotepa in the treatment of advanced breast cancer.
por: Lyons, A. R., et al.
Publicado: (1965)

Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)
por: Ajrouche, R, et al.
Publicado: (2015)

Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol
por: Winnicki, Camille, et al.
Publicado: (2023)

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers
por: Jannier, Sarah, et al.
Publicado: (2020)

The Combined Thiotepa and Testosterone Treatment of Cancer of the Breast
por: Brown, I. Scott, et al.
Publicado: (1964)

High-dose chemotherapy followed by whole lung irradiation in pulmonary relapse Ewing’s sarcomas: a retrospective multicenter study
por: Duverge, Loig, et al.
Publicado: (2022)

MBCL-22. EFFICACY OF DOUBLE-CONDITIONING REGIMEN COMPRISING THIOTEPA AND MELPHALAN FOR RELAPSED MEDULLOBLASTOMA – A SINGLE INSTITUTION EXPERIENCE
por: Yamasaki, Kai, et al.
Publicado: (2020)

High-dose thiotepa-related neurotoxicity and the role of tramadol in children
por: Maritaz, Christophe, et al.
Publicado: (2018)

Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
por: Gomez-Brouchet, Anne, et al.
Publicado: (2021)

Solitary Fibrous Tumors and So-Called Hemangiopericytoma
por: Penel, Nicolas, et al.
Publicado: (2012)

Effects of thiotepa on primary cultures of DMBA-induced mammary tumours of rats: kinetics and ultrastructure.
por: Fink, S. M., et al.
Publicado: (1981)

Electron microscope studies on the effect of thiotepa on the cytoplasm of fibrosarcoma cells grown in tissue culture.
por: Barton, A. A., et al.
Publicado: (1965)

Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment
por: Linxweiler, Helen, et al.
Publicado: (2023)

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
por: Saraceni, Francesco, et al.
Publicado: (2019)

Apatinib plus ifosfamide and etoposide for relapsed or refractory osteosarcoma: A retrospective study in two centres
por: Xie, Lu, et al.
Publicado: (2021)

Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa
por: Wagh, Himanshu, et al.
Publicado: (2022)

Osteosarcoma
por: Philip, T, et al.
Publicado: (2001)

Osteosarcoma relapse as pleural metastasis
por: Saha, Debabrata, et al.
Publicado: (2013)

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
por: Baruchel, André, et al.
Publicado: (2020)

Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings
por: Dufresne, Armelle, et al.
Publicado: (2012)

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience
por: Schrama, J G, et al.
Publicado: (2003)

Large indoor cage study of the suppression of stable Aedes aegypti populations by the release of thiotepa-sterilised males
por: Gato, René, et al.
Publicado: (2014)

Pulmonary arterial hypertension in pediatric patients undergoing high-dose carboplatin/thiotepa and stem cell transplant
por: Hackett, Gretchen, et al.
Publicado: (2021)

Percutaneous Core Needle Biopsy Can Efficiently and Safely Diagnose Most Primary Bone Tumors
por: Crenn, Vincent, et al.
Publicado: (2021)

Ewing’s Sarcoma of the Head and Neck: Margins are not just for surgeons
por: Bouaoud, Jebrane, et al.
Publicado: (2018)

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
por: Rouger-Gaudichon, Jérémie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gnh7ui8b2rh8a0uh74etibbsqr